ExploreCME: Diving deep into PANCE Prep!

VT to VF: Rogue Beats, Critical Decisions

Subscriber Episode • • Phillip

Share episode

This episode is only available to subscribers.

ExploreCME: Diving deep into PANCE Prep! +

Get access to our entire back catalogue
SPEAKER_01:

Welcome back to the Deep Dive, where we break down some of the most complex clinical topics into something you can actually use.

SPEAKER_00:

And today we're tackling two big ones. I mean, truly terrifying words in cardiology, ventricular tachycardia and ventricular fibrillation.

SPEAKER_01:

Right. These aren't just squiggles on an ECG you need to recognize for a test. They're they're immediate life or death situations.

SPEAKER_00:

Absolutely. And for any provider, being able to tell them apart, and more importantly, knowing what to do in that first minute based on whether your patient is stable or not, that is a non-negotiable skill.

SPEAKER_01:

Aaron Powell That's the whole mission today. We're going deep on that critical decision point. When do you shock? When do you push drugs? We've synthesized the foundational science, the diagnostics, and the long-term management to get you ready.

SPEAKER_00:

Aaron Powell So let's dive in. Let's start with the first one ventricular tachycardia or VT, the uh organized chaos.

SPEAKER_01:

Aaron Powell Okay. So definition first, what are we actually talking about?

SPEAKER_00:

Aaron Powell We're talking about three or more ventricular premature beats all in a row. But the first uh the first clinical question is always about timing.

SPEAKER_01:

The 30-second rule.

SPEAKER_00:

Exactly. It all boils down to a 30-second timer. If it stops on its own in under 30 seconds, we call that non-sustained VT.

SPEAKER_01:

And if it goes longer.

SPEAKER_00:

If it lasts more than 30 seconds, or, and this is critical, if it causes the patient to collapse hemodynamically, that's sustained VT. And that distinction right there changes everything about what you do next.

SPEAKER_01:

Let's talk about why it's happening. The etiology. You have to immediately ask: is this a healthy heart or a damaged one?

SPEAKER_00:

That's the fundamental split. You have to divide them into two camps. First, you have the structurally normal heart, we call this idiopathic VT.

SPEAKER_01:

And that's usually less dangerous.

SPEAKER_00:

Much less. It often comes from a specific spot, like the outflow tracks, and the prognosis is generally pretty good. But then you have the danger zone. The scructural heart disease. Yes. And in older patients, the most common cause by far is ischemic heart disease. A previous heart attack, maybe even one they didn't know they had, leaves behind scar tissue.

SPEAKER_01:

And that scar becomes the circuit for the VT.

SPEAKER_00:

Precisely. You also see it with cardiomyopathies dilated or hypertrophic or myocarditis. But that old MI scar, that's the classic setup.

SPEAKER_01:

Okay, we have to mention the special variant. Torsads de point.

SPEAKER_00:

Ah, yes.

SPEAKER_01:

PDP.

SPEAKER_00:

The one that looks like it's twisting on the EKG. What makes it so different? Torsads is unique because it's all about electrical timing. It's a polymorphic VT that's directly linked to a prolonged QT interval.

SPEAKER_01:

So the cause isn't a scar, it's an electrical problem.

SPEAKER_00:

It's an electrical problem that's often triggered by really simple correctable things. Low potassium, low magnesium, or you have to look really closely at their medication list for QT prolonging drugs.

SPEAKER_01:

Which means the treatment is totally different.

SPEAKER_00:

Totally different.

SPEAKER_01:

Okay, so let's move to the bedside. History taking. What is the patient actually going to complain about?

SPEAKER_00:

Well, it's a huge spectrum. You might have someone who is completely asymptomatic, you just happen to catch it on a monitor.

SPEAKER_01:

An incidental finding it right.

SPEAKER_00:

Or they could come in with palpitations, shortness of breath, feeling lightheaded. But in a patient with that underlying structural disease, the presentation can be syncope or just boom, cardiac arrest.

SPEAKER_01:

So your history has to dig for those risk factors.

SPEAKER_00:

Absolutely. Yeah. Do they have a prior MI? Is there a family history of anyone dying suddenly? Yeah. That could point to an inherited arrhythmia. And again, you have to get a rock solid medication history.

SPEAKER_01:

And ask about triggers, right?

SPEAKER_00:

Oh yes. Does it happen with exercise or after major emotional stress? Those are critical clues.

SPEAKER_01:

All right, let's get to the diagnostic challenge. This is a huge pansy topic. You see a wide complex tachycardia. How do you prove it's VT and not say SVT with aberrantcy?

SPEAKER_00:

This is the ECG deep dive.

SPEAKER_01:

Yeah.

SPEAKER_00:

You're looking for proof that the ventricles are doing their own thing, completely ignoring the atria. There are a few key signs.

SPEAKER_01:

Okay, what's number one?

SPEAKER_00:

A V dissociation. This means the P waves from the atria are just marching along at their own rate, and the QRS complexes from the ventricle are firing at a totally different, faster rate. They're not talking to each other.

SPEAKER_01:

The ventricle has gone rogue.

SPEAKER_00:

It's gone rogue. And that proves the rhythm is ventricular. The second thing you look for are capture or fusion beats.

SPEAKER_01:

What are those?

SPEAKER_00:

A capture beat is when for just one moment a normal signal from the atria manages to capture the ventricle and produce a normal narrow QRS beat in the middle of all that wide stuff.

SPEAKER_01:

A little island of normal?

SPEAKER_00:

Exactly. And a fusion beat is sort of a hybrid. Both of those are dead giveaways for VT.

SPEAKER_01:

And the third clue is the QRS itself, right? The morphology.

SPEAKER_00:

Right. If that QRS is super wide, I mean wider than 0.14 seconds, that strongly, strongly favors VT. You can also see things like an extreme axis deviation or what we call precordial concordance, where all the chest leads are pointing in the same direction, either all up or all down.

SPEAKER_01:

Okay, so on the diagnostic studies front, what are you ordering immediately?

SPEAKER_00:

Acutely, you need electrolytes. You have to rule out low potassium or magnesium. If you suspect ischemia, you need troponins.

SPEAKER_01:

And long term, once they're stable?

SPEAKER_00:

Long term, it's all about imaging. You need an echocardiogram, maybe a cardiac MRI, to really map out that structure. Is there a scar? How bad is the cardiomyopathy? And many of these patients will need an angiogram to check the coronary arteries.

SPEAKER_01:

Now for the moment of truth, clinical intervention. The entire algorithm hinges on one word stability. If the patient is unstable, they're hypotensive, they're in heart failure, they're having chest pain, what do you do?

SPEAKER_00:

You don't think. You act. Immediate, synchronized, direct current cardioversion. 100 to 200 joules. That's the answer. There is no time for drugs.

SPEAKER_01:

But what if they're stable? They're talking to you, maybe a little lightheaded, but their pressure's okay.

SPEAKER_00:

If they're stable, now you have time for pharmacologic cardioversion. And the go-to drug, especially if there's structural heart disease, is ibay amiodurone.

SPEAKER_01:

The 150 milligram bolus.

SPEAKER_00:

The 150 milligram bolus followed by continuous infusion. You could also consider lidocaine or perkanamide, but amyodurone is really the workhorse.

SPEAKER_01:

Well, wait. What about torsods? We don't use amyodurone for that, do we?

SPEAKER_00:

No, you don't. Because torsods, remember, is an electrical instability problem from a long QT. The immediate empiric treatment is IV magnesium, one to two grams.

SPEAKER_01:

Why magnesium?

SPEAKER_00:

It helps stabilize the cardiac cell membrane and stops the electrical problem that leads to TDP. If it keeps coming back, you actually have to speed the heart rate up with something like isoproterinol or a temporary pacemaker.

SPEAKER_01:

Because a faster heart rate shortens the QT interval.

SPEAKER_00:

Exactly. You fix the underlying electrical problem.

SPEAKER_01:

Let's shift to long-term management and prevention. The patient survived. Now what?

SPEAKER_00:

For a patient with structural heart disease who had sustained VT, the answer is almost always an implantable cardioverter defibrillator, an ICD. That's what provides secondary prevention.

SPEAKER_01:

So the device is what saves their life down the road. What about medications?

SPEAKER_00:

Medications are important, but for a different reason. Beta blockers are the mainstay. Antiarrhythmics like amioderone can reduce how often the ICD has to fire, which is important for quality of life, but they generally do not improve overall mortality. The device does that.

SPEAKER_01:

That's a huge distinction for exams. Device for mortality, drugs for symptoms.

SPEAKER_00:

A critical distinction.

SPEAKER_01:

And is there anything curative?

SPEAKER_00:

For some types, yes. Catherablation can be curative, especially for those benign, idiopathic VTs. It has a very high success rate. We also use it for patients with ischemic cardiomyopathy who keep having VT storms or can't tolerate the meds.

SPEAKER_01:

Okay, let's pivot from organized chaos to just complete anarchy. Ventricular fibrillation and sudden cardiac death.

SPEAKER_00:

Right. So sudden cardiac death or SED has a specific definition. It's an unexpected, non-traumatic death that happens within one hour of when symptoms start. And when you look at the rhythm that causes it, it's overwhelmingly VF, just a chaotic, quivering ventricle that isn't pumping any blood.

SPEAKER_01:

The etiology here is super important because it splits completely based on age.

SPEAKER_00:

A massive split. If your patient is over 35, you should be thinking coronary heart disease. It accounts for something like 70% of cases. It's a plumbing problem.

SPEAKER_01:

But if they're under 35, it's a totally different world.

SPEAKER_00:

You're looking at inherited disorders, electrical wiring problems we call channelopathies, or inherited structural problems like hypertrophic cardiomyopathy.

SPEAKER_01:

Can you just quickly name the big channelopathies we need to know?

SPEAKER_00:

The big three are long QT syndrome, Brugata syndrome, which has that classic ECG pattern in V1 to V3, and arrhythmogenic RV cardiomyopathy.

SPEAKER_01:

Got it. Now let's say we get them back, we successfully resuscitate them, the focus immediately shifts to post-arrest care.

SPEAKER_00:

Right. And you have two priorities. Save the heart, save the brain. If you suspect ischemia was the trigger, they need to go to the calf lab for revascularization immediately.

SPEAKER_01:

And for the brain.

SPEAKER_00:

Targeted temperature management. TTM. This is standard of care.

SPEAKER_01:

This isn't just a suggestion, it's a critical intervention.

SPEAKER_00:

It's life-altering. You rapidly core the patient down to somewhere between 32 and 36 degrees Celsius, and you keep him there for a full 24 to 36 hours. This has been proven to dramatically improve neurologic outcomes.

SPEAKER_01:

For long-term health maintenance for that survivor who gets an ICD.

SPEAKER_00:

The short answer is pretty much everyone. If you survived a sudden cardiac death that wasn't from a clearly reversible cause like a freak electrolyte problem you fixed, the risk of it happening again is very high. You get an ICD.

SPEAKER_01:

And what if you can't put one in right away? Maybe post-MI when the heart might recover.

SPEAKER_00:

That's where the wearable cardiovert defibrillator or the life vest comes in. It's a temporary bridge. It protects the patient while you're waiting to see if their heart function improves enough to not need a permanent device.

SPEAKER_01:

Okay, let's synthesize all of this. High yield takeaways for the exam.

SPEAKER_00:

Let's do it. For pharmaceutical therapeutics, torsoids gets IV magnesium, 1 to 2 grams. Stable VT gets IV amyoderone, 150 milligram bolus, nailed down.

SPEAKER_01:

Using diagnostics. That ECG differentiation is key. QRS wider than 0.14 seconds, AV dissociation, fusion beats. That's VT. Post-arrest, always check for ischemia and electrolytes.

SPEAKER_00:

For clinical intervention, know the stability algorithm cold. Unstable VT gets a shock, stable VT gets a drug. And for the SED survivor, that TTM window is 24 to 36 hours.

SPEAKER_01:

And finally, health maintenance. In older patients, screen for ischemic disease. In younger patients, look for those inherited channelopathies. And every single SCD survivor needs a referral to cardiology and EP.

SPEAKER_00:

To really make this stick, let's use that engine analogy.

SPEAKER_01:

I like this one. So VT versus VF. Give us the simple version.

SPEAKER_00:

Okay, think of the heart as an engine. Ventricular tachycardia is like a race car engine stuck at max RPM, but it's in neutral.

SPEAKER_01:

So it's organized, it's fast.

SPEAKER_00:

It's organized and fast, but it's spinning too fast to actually fill with fuel. The output is dangerously low. That's why patients get symptomatic.

SPEAKER_01:

And ventricular fibrillation.

SPEAKER_00:

VF is the engine seizing up and shaking violently. The electrical activity is complete chaos. There's zero organized contraction, which means zero output, immediate cardiac arrest.

SPEAKER_01:

So organized but inefficient versus total catastrophic failure.

SPEAKER_00:

That's the difference.

SPEAKER_01:

So for you listening, mastering this distinction, VT versus VF, and knowing that immediate next step based on stability, that is the core of cardiovascular emergency medicine.

SPEAKER_00:

And here's a final thought to leave you with.

SPEAKER_01:

A huge thank you for walking us through that. Go master those wide complex tachycardias, and we'll see you on the next deep dive.